You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

growth hormone receptor antagonist,

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Preimplantation Genetic Testing, Growth Hormone, Age, Parental Trial (Growth Hormone, GnRH antagonist)

Recruiting
  • Preimplantation Genetic Testing
  • +2 more
  • Growth Hormone
  • GnRH antagonist
  • Shanghai, Shanghai, China
    Shanghai JIAI Genetics and IVF Institute
Oct 8, 2022

Growth Hormone, Advanced Maternal Age, PGT-A Trial in Shanghai (Growth hormone, GnRH antagonist)

Completed
  • Growth Hormone
  • +2 more
  • Growth hormone
  • GnRH antagonist
  • Shanghai, Shanghai, China
    Shanghai JIAI Genetics and IVF Institute
Oct 8, 2022

Metastatic Breast Cancer, Locally Advanced Breast Cancer, Breast Cancer Trial in Ocala (Samuraciclib, Fulvestrant)

Recruiting
  • Metastatic Breast Cancer
  • +2 more
  • Ocala, Florida
    Ocala Oncology Center PL DBA Florida Cancer Affiliates
Jul 19, 2023

HR+/HER2- Advanced Breast Cancer, Targeted Therapy Trial in Beijing (Everolimus, Chidamide, Endocrine therapy)

Recruiting
  • HR+/HER2- Advanced Breast Cancer
  • Targeted Therapy
  • Beijing, Beijing, China
    National Cancer Center/National Clinical Research Center for Can
Aug 1, 2023

Insulin Receptor Mutation, Partial Lipodystrophy Trial run by the National Institute of Diabetes and Digestive and Kidney

Not yet recruiting
  • Insulin Receptor Mutation
  • Partial Lipodystrophy
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 17, 2022

Locally Advanced or Unresectable Metastatic Breast Cancer, Stage IV Breast Cancer Trial in Marietta, East Brunswick (Sacituzumab

Recruiting
  • Locally Advanced or Unresectable Metastatic Breast Cancer
  • Stage IV Breast Cancer
  • Sacituzumab Govitecan-hziy
  • +3 more
  • Marietta, Georgia
  • +1 more
Apr 21, 2023

Female Infertility Due to Diminished Ovarian Reserve Trial in Cairo (Growth Hormone)

Completed
  • Female Infertility Due to Diminished Ovarian Reserve
  • Growth Hormone
  • Cairo, Egypt
    Kasr Al Aini
Nov 4, 2021

Hormone Receptor Positive HER-2 Negative Breast Cancer Trial in Shanghai (Docetaxel, Carboplatin, Epirubicin)

Recruiting
  • Hormone Receptor Positive HER-2 Negative Breast Cancer
  • Shanghai, Shanghai, China
    Breast cancer institute of Fudan University Cancer Hospital
Jun 12, 2023

Metastatic Breast Cancer Trial in Spain (Pembrolizumab, Paclitaxel)

Active, not recruiting
  • Metastatic Breast Cancer
  • Hospitalet de Llobregat, Barcelona, Spain
  • +6 more
Jan 23, 2023

Hepatocellular Carcinoma, Pancreatic Ductal Adenocarcinoma, Biliary Tract Cancers Trial (ABBV-400)

Not yet recruiting
  • Hepatocellular Carcinoma
  • +6 more
  • (no location specified)
Oct 10, 2023

Breast Cancer, Breast Cancer Metastatic, Hormone Receptor Positive Tumor Trial (INX-315)

Not yet recruiting
  • Breast Cancer
  • +8 more
  • (no location specified)
Feb 9, 2023

Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, HER2-Negative Breast Carcinoma Trial in

Not yet recruiting
  • Anatomic Stage II Breast Cancer AJCC v8
  • +3 more
  • Biospecimen Collection
  • +7 more
  • Portland, Oregon
    SWOG
Sep 27, 2023

Breast Cancer Stage II Trial in Xi'an (Anlotinib)

Recruiting
  • Breast Cancer Stage II
  • Xi'an, Shannxi Province, China
    Xijing Hospital Affiliated to Air Force Military Medical Univers
Sep 25, 2022

Female Infertility Trial in Alexandria (Growth Hormone)

Completed
  • Female Infertility
  • Growth Hormone
  • Alexandria, Egypt
    faculty of medicine, Alexandria University
Aug 8, 2022

Metastatic Breast Cancer Trial in Zhengzhou (Famitinib, SHR6390, Fulvestrant)

Recruiting
  • Metastatic Breast Cancer
  • Zhengzhou, Henan, China
    Henan Cancer Hospital
Jan 25, 2022

Breast Cancer Trial in Shanghai (HS-10352 combined with fulvestrant (Stage 1), HS-10352 combined with fulvestrant (Stage 2))

Recruiting
  • Breast Cancer
  • HS-10352 combined with fulvestrant (Stage 1)
  • HS-10352 combined with fulvestrant (Stage 2)
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Aug 15, 2022

Hypertension, Pulmonary Arterial Hypertension, Familial Primary Pulmonary Hypertension Trial in Nashville (Tamoxifen, Placebo

Recruiting
  • Hypertension
  • +8 more
  • Nashville, Tennessee
    Vanderbilt University Medical Center
Aug 22, 2022

Metastatic Breast Cancer Trial in Dallas (DB-1303, Capecitabine, Paclitaxel)

Not yet recruiting
  • Metastatic Breast Cancer
  • Dallas, Texas
    Texas Oncology - Baylor Charles A. Sammons Cancer Center
Aug 25, 2023

Breast Cancer, Chemo Effect Trial (Capecitabine)

Not yet recruiting
  • Breast Cancer
  • Chemotherapy Effect
  • (no location specified)
Mar 9, 2022

Among Patients Receiving Palbociclib Combinations for Hormone

Recruiting
  • Breast Neoplasms
  • Palbociclib plus an aromatase inhibitor
  • Palbociclib plus fulvestrant
  • Doha, Qatar
    Hamad Medical Corporation
Nov 18, 2021

Breast Cancer, Invasive Breast Cancer, Unresectable Breast Carcinoma Trial in Boston (Onvansertib, Paclitaxel)

Recruiting
  • Breast Cancer
  • +9 more
  • Boston, Massachusetts
  • +2 more
Oct 25, 2022

Fibrosis Trial in Aarhus (Growth hormone, saline and GH receptor blockade (Pegvisomant))

Recruiting
  • Fibrosis
  • Growth hormone, saline and GH receptor blockade (Pegvisomant)
  • Aarhus, Denmark
    Aarhus University
Aug 31, 2021

Breast Cancer Trial in Egypt

Completed
  • Breast Cancer
    • Alexandria, Egypt
    • +7 more
    Jan 24, 2022

    HR-positive, HER2-negative Breast Tumors Trial in China (TQB3616 capsule, Placebo, Fulvestrant injection)

    Not yet recruiting
    • HR-positive, HER2-negative Breast Neoplasms
    • TQB3616 capsule
    • +2 more
    • Bengbu, Anhui, China
    • +5 more
    May 6, 2022

    Breast Cancer, Invasive Breast Cancer Trial in Milwaukee (Anastrozole, Letrozole, Exemestane)

    Active, not recruiting
    • Breast Cancer
    • Invasive Breast Cancer
    • Milwaukee, Wisconsin
      Froedtert Hospital
    Sep 16, 2021